The Efficacy and Safety of Rifaximin for the Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Efficacy and Safety of Rifaximin for the Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis
Authors
Keywords
-
Journal
AMERICAN JOURNAL OF GASTROENTEROLOGY
Volume 107, Issue 1, Pages 28-35
Publisher
Springer Nature
Online
2011-11-01
DOI
10.1038/ajg.2011.355
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Food: The Forgotten Factor in the Irritable Bowel Syndrome
- (2011) Shanti Eswaran et al. GASTROENTEROLOGY CLINICS OF NORTH AMERICA
- Rifaximin Therapy for Patients with Irritable Bowel Syndrome without Constipation
- (2011) Mark Pimentel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Abnormal Breath Testing in IBS: A Meta-Analysis
- (2010) Eric D. Shah et al. DIGESTIVE DISEASES AND SCIENCES
- Rifaximin intake leads to emergence of rifampin-resistant staphylococci
- (2010) Thomas Valentin et al. JOURNAL OF INFECTION
- An Evidence-Based Position Statement on the Management of Irritable Bowel Syndrome
- (2009) AMERICAN JOURNAL OF GASTROENTEROLOGY
- The Utility of Probiotics in the Treatment of Irritable Bowel Syndrome: A Systematic Review
- (2009) Darren M Brenner et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Rifaximin Redux: Treatment of recurrent Clostridium difficile infections with Rifaximin immediately post-vancomycin treatment
- (2009) Stuart Johnson et al. ANAEROBE
- Microbial community analysis reveals high level phylogenetic alterations in the overall gastrointestinal microbiota of diarrhoea-predominant irritable bowel syndrome sufferers
- (2009) Lotta Krogius-Kurikka et al. BMC GASTROENTEROLOGY
- Small Intestinal Bacterial Overgrowth in Irritable Bowel Syndrome: Systematic Review and Meta-analysis
- (2009) Alexander C. Ford et al. Clinical Gastroenterology and Hepatology
- A Molecular Analysis of Fecal and Mucosal Bacterial Communities in Irritable Bowel Syndrome
- (2009) Caroline Codling et al. DIGESTIVE DISEASES AND SCIENCES
- Review of rifaximin as treatment for SIBO and IBS
- (2009) Mark Pimentel EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Early Life Risk Factors That Contribute to Irritable Bowel Syndrome in Adults: A Systematic Review
- (2008) Denesh K. Chitkara et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- T1390 Rifaximin for the Treatment of Diarrhea-Associated Irritable Bowel Syndrome: Short Term Treatment Leading to Long Term Sustained Response
- (2008) Anthony Lembo et al. GASTROENTEROLOGY
- Reduced Brainstem Inhibition during Anticipated Pelvic Visceral Pain Correlates with Enhanced Brain Response to the Visceral Stimulus in Women with Irritable Bowel Syndrome
- (2008) S. M. Berman et al. JOURNAL OF NEUROSCIENCE
- Brain imaging of visceral functions in healthy volunteers and IBS patients
- (2008) Nora Rapps et al. JOURNAL OF PSYCHOSOMATIC RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation